Skip to main content
DC 7005Cardiovascular System

Secondary Conditions for Arteriosclerotic Heart Disease (Coronary Artery Disease)

4 conditions have documented medical links to Arteriosclerotic Heart Disease (Coronary Artery Disease). These may qualify as secondary service-connected disabilities if you can establish a medical nexus.

Evidence Strength:STRONGMODERATEEMERGING
MODERATE

Medical Rationale

OSA and coronary artery disease have a well-documented bidirectional relationship, and CAD can precipitate or worsen OSA through cardiac-related mechanisms. Reduced cardiac output from CAD-related left ventricular dysfunction promotes "cardiac OSA" — fluid redistribution from the lower extremities to the neck in the supine position during sleep causes pharyngeal edema and upper airway narrowing. Additionally, the autonomic dysregulation produced by myocardial ischemia — specifically impaired baroreflex sensitivity and elevated sympathetic tone — reduces the ventilatory response and arousal threshold during apnea, permitting longer and more severe apnea events. Studies in heart failure populations document OSA prevalence of 40–60%. Post-MI autonomic dysfunction is independently associated with sleep-disordered breathing development.

Key Studies

Javaheri S et al. (2011) Chest (sleep apnea in heart failure); Mehra R et al. (2006) JACC (Sleep Heart Health Study and coronary artery calcium); Yumino D & Bradley TD (2008) J Am Coll Cardiol; Bradley TD & Floras JS (2009) Lancet (sleep apnea and cardiovascular disease).

Filing Tips

Polysomnography documenting OSA diagnosis (AHI, oxygen desaturation index, apnea type). Cardiology records documenting CAD and any echocardiographic evidence of left ventricular dysfunction. A nexus letter from your cardiologist or sleep medicine physician addressing fluid redistribution, autonomic dysfunction, or reduced baroreflex sensitivity as the mechanism. If OSA was diagnosed temporally after CAD, the chronology supports the secondary claim.

STRONG

Medical Rationale

Erectile dysfunction is strongly associated with coronary artery disease and shares the same underlying pathophysiology — endothelial dysfunction and atherosclerosis. In fact, ED precedes cardiac events by an average of 3–5 years and is now recognized as an early warning sign of subclinical CAD. The penile arteries (cavernous arteries, 1–2 mm diameter) are smaller than coronary arteries (3–4 mm) and therefore develop atherosclerotic occlusion earlier for any given plaque burden. Once CAD is established, reduced penile perfusion is universal. Beta-blockers and thiazide diuretics commonly prescribed for CAD independently cause ED as dose-dependent side effects. The combination of vascular, neurogenic (reduced autonomic tone post-MI), and medication-induced ED in CAD patients is clinically recognized.

Key Studies

Thompson IM et al. (2005) J Urol (ED as predictor of cardiovascular events); Montorsi P et al. (2006) Eur Urol (artery size hypothesis); Feldman HA et al. (1994) J Urol (MMAS epidemiology); Inman BA et al. (2009) Mayo Clin Proc.

Filing Tips

Urology records documenting ED diagnosis, evaluation (including penile Doppler ultrasound showing reduced cavernous artery peak systolic velocity), and treatment trial with PDE-5 inhibitors. Cardiology records documenting CAD and medications. A nexus letter from your urologist or cardiologist connecting penile vascular disease as part of the systemic atherosclerosis of CAD. File for SMC-K ($118/month) if erectile function cannot be restored with medication.

STRONG

Medical Rationale

Depression and anxiety are among the most clinically significant complications of coronary artery disease (CAD). The prevalence of major depression following myocardial infarction is 15–20%, compared to 5–7% in the age-matched general population. Pathophysiological mechanisms are bidirectional and well-established: CAD-induced myocardial ischemia activates the sympathetic nervous system and HPA axis, producing the same cortisol dysregulation and monoamine depletion that characterize primary depression. Inflammatory cytokines (IL-6, TNF-alpha, CRP) that drive atherosclerosis also cross the blood-brain barrier to suppress neurogenesis and deplete serotonin. The psychosocial burden of cardiac diagnosis — fear of sudden death, activity restriction, sexual dysfunction, occupational disability — provides powerful psychological stressors. Post-MI depression independently triples the risk of subsequent cardiac events, making treatment of secondary depression medically urgent.

Key Studies

Frasure-Smith N & Lesperance F (2008) Psychosom Med (post-MI depression and mortality); Lichtman JH et al. (2008) Circulation (AHA scientific statement on depression and CAD); Carney RM & Freedland KE (2003) J Psychosom Res; Nicholson A et al. (2006) Eur Heart J (meta-analysis).

Filing Tips

Psychiatric records documenting depression or anxiety disorder onset or significant worsening following CAD diagnosis, cardiac hospitalization, or cardiac procedure. A nexus letter from your cardiologist and/or psychiatrist stating that depression is "at least as likely as not" caused or worsened by the service-connected cardiac condition. The AHA now routinely screens cardiac patients for depression, so many hospital records will document post-cardiac depression explicitly. File depression as secondary to CAD for additive rating benefit.

STRONG

Medical Rationale

Coronary artery disease and peripheral artery disease are manifestations of the same systemic atherosclerotic disease process. Risk factors — hypertension, diabetes, dyslipidemia, and smoking — produce generalized endothelial dysfunction and plaque formation in both coronary and peripheral arterial beds. Approximately 40–60% of patients with established CAD have concurrent PAD (defined as ABI < 0.90), and PAD patients have a 2–3-fold increased risk of fatal MI and stroke from co-existing coronary disease. The same inflammatory, thrombotic, and lipid-mediated mechanisms that cause coronary atherosclerosis simultaneously advance peripheral arterial occlusive disease. Veterans with service-connected CAD therefore have a well-established biological mechanism for developing PAD as a secondary or concurrent condition.

Key Studies

Hirsch AT et al. (2001) Circulation (PAD and cardiovascular risk); Bhatt DL et al. (2006) JACC (REACH Registry — polyvascular disease); Sigvant B et al. (2009) Eur J Vasc Endovasc Surg (CAD and PAD comorbidity); Murabito JM et al. (1997) Circulation (Framingham PAD and cardiac risk).

Filing Tips

Vascular laboratory documentation: ankle-brachial index (ABI < 0.90 at rest or < 0.73 after exercise), segmental pressure measurement, or toe-brachial index. Vascular surgery or cardiology records documenting PAD diagnosis (claudication, rest pain, or tissue loss). A nexus letter addressing polyvascular atherosclerotic disease — the same systemic pathology causing CAD also causing PAD — from a cardiologist or vascular surgeon. PAD rated under DC 7115 based on ABI, claudication distance, and whether rest pain or tissue loss is present (20–100%).

← Back to Arteriosclerotic Heart Disease (Coronary Artery Disease) rating criteria

Find All Secondary Conditions for Your Situation

AIDEN can analyze your complete medical history and identify secondary conditions specific to your case, including connections that may not appear in standard databases.

Discover Your Secondary Conditions